Did You Know...
...that on Dec. 15, 1836, the Patent Office was completely destroyed by fire? Lost were some 7,000 models, 9,000 drawings, and 230 books plus all records of patent applications and grants.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4843071 | Method and composition for treating obesity, drug abuse, and narcolepsy Compositions and methods are disclosed for the treatment of obesity, depression, drug abuse, and narcolepsy. The compositions comprise a norepinephrine precursor such as L-tyrosine or L-phenylalanine in combination with a norepinephrine re-uptake inhibito... | 06/27/1989 |
| 4833128 | Dietary supplement A dietary supplement formulated to suppress appetite comprising L-phenylalanine in combination with restricted quantities of protein, carbohydrate, fat and dietary fiber.... | 05/23/1989 |
| 4822776 | Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) A mediator substance exhibiting inhibitory effect upon anabolic enzyme activity in mammals, is prepared by a method comprising gathering a sample of macrophage cells from a mammal, incubating a portion of the macrophage cells with a stimulating mate This ... | 04/18/1989 |
| 4789687 | Food containing vanillylamine and derivatives useful for accellerating lipid metabolism A food product comprising a food substance in combination with vanillylamine or a vanillylamide.... | 12/06/1988 |
| 4745122 | Method for treating obesity A method for treating obesity in humans or non-human animals, which method comprises administering an effective, non-toxic amount of paroxetine or a pharmaceutically acceptable salt thereof, to obese humans or animals and compositions for use in such trea... | 05/17/1988 |
| 4716177 | Tolrestat for inhibition of weight gain A method is disclosed for inhibiting weight gain by administering an effective amount of tolrestat.... | 12/29/1987 |
| 4680313 | Acceleration of lipid metabolism using vanillylamine derivatives A food product comprising a food substance in combination with vanillylamine or a vanillylamide.... | 07/14/1987 |
| 4673691 | Human weight loss inducing method A human weight reduction method in which 2,4-dinitrophenol and a thyroid hormone preparation are administered to the patient. The dinitrophenol is administered in dosages sufficient to elevate the patient's body temperature, typically 250 mg every other d... | 06/16/1987 |
| 4666898 | Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones Obesity, diabetes obesity syndromes and associated hypercorticoidism are treated with and/or ଲ-etiocholanolone.... | 05/19/1987 |
| 4654371 | Secondary amines, their preparation and use in pharmaceutical compositions The compounds of the formula (II): ##STR1## and their pharmaceutically acceptable salts wherein R1 is a hydrogen, fluorine or chlorine atom or a hydroxyl, hydroxymethyl, methyl, methoxyl, amino, formamido, acetamido, methylsulphonylamido, ... | 03/31/1987 |
| 4617298 | Method and compositions for weight control The invention provides a method for controlling mammalian body weight using a compound of the formula or a non-toxic pharmaceutically acceptable salt thereof, wherein [E] is an estrogen and [DHC] is the reduced, biooxidizable, blood-brain barrier penetrat... | 10/14/1986 |
| 4598089 | Leucine derivatives Novel compounds of the formula ##STR1## wherein A signifies the group ##STR2## or --(CH2)5 --, which inhibit pancreas lipase and can be used for the control or prevention of obesity and hyperlipaemia, are disclosed. Th... | 07/01/1986 |
| 4591594 | Thromboxane synthase inhibitors as antiobesity agents The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted... | 05/27/1986 |
| 4588724 | Treatment for selective reduction of regional fat deposits A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or an alpha-2 adrenergic inhibitor, is selectively delivered to a regional fa... | 05/13/1986 |
| 4585796 | Novel phenethanolamines The tertiary amines of the formula ##STR1## wherein n represents a whole number of 1 to 5; X1 represents phenyl or phenyl mono-, di- or tri-substituted by R1, R2 and R3 ; X2 represents hydrogen, lower... | 04/29/1986 |
| 4548937 | Method for preventing body fat deposition in mammals A method for reducing the weight gain in mammals by orally administering over a prolonged period therapeutically effective amounts of pyruvate to which may be added riboflavin. The method also has the effect of increasing the body protein concentration.... | 10/22/1985 |
| 4530936 | Composition and method for inhibiting the absorption of nutritional elements from the upper intestinal tract A method of inhibiting the absorption of nutritional elements, principally food, from the gastrointesinal tract is disclosed which comprises ingesting perfluorodecalin in an amount sufficient to form a nutritional element-impermeable film thereof on at le... | 07/23/1985 |
| 4478849 | Secondary amines, their preparation and use in pharmaceutical compositions The compounds of the formula (II): ##STR1## and their pharmaceutically acceptable salts wherein R1 is a hydrogen, fluorine or chlorine atom or a hydroxyl, hydroxymethyl, methyl, methoxyl, amino, formamido, acetamido, methylsulphonylamido, ... | 10/23/1984 |
| 4470975 | Method and composition for the elimination of water from an animal body It has been found that certain insoluble hydrophilic cross-linked polysaccharides are useful pharmaceutical agents in diverting water elimination from the renal route to the gastrointestinal route, and removing excess water from the body by the gastrointe... | 09/11/1984 |
| 4466978 | Bodyweight reducing method The present invention provides in one aspect a slimming method and in a further aspect a method for the treatment or prophylaxis of obesity, comprising the administration of a bodyweight reducing effective dosage of a compound selected from glutathione, p... | 08/21/1984 |
| 4465684 | 3,4,5-Trihydroxypiperidine compounds and their use as medicaments and in animal nutrition The invention relates, inter alia, to 3,4,5-trihydroxypiperidine compounds of Formula (I), infra, to methods for the manufacture of said compounds, to pharmaceutical compositions containing said compounds and to methods for the use of said compounds and c... | 08/14/1984 |
| 4446138 | Method and composition for reducing weight A method for reducing weight by the administration of L-Dopa or a stabilized form thereof with or without a decarboxylase inhibitor and Molindone wherein Molindone acts as a potentiator to enhance the weight reducing potency of L-Dopa in warm-blooded anim... | 05/01/1984 |
| 4432993 | Method of treating obesity hyperglycemia, inflammation and platelet aggregation A compound of formula (I): ##STR1## wherein R1 and R2 are hydrogen or methyl, R3 is hydroxy, hydroxyalkoxy, benzyloxy or wherein (i) X is a bond or oxygen, Y is C1-6 straight or branched alkylene, and Z is hydrogen o... | 02/21/1984 |
| 4428963 | Novel thiophene derivatives Thiophene derivatives having utility as blood lipid lowering agents and as antiobesity agents are disclosed.... | 01/31/1984 |
| 4396627 | Secondary amines, their preparation and use in pharmaceutical compositions Compounds having the formula: ##STR1## where R1, R2, R3, R4, R5, Y and X are as defined hereinbelow, are useful for the reduction of abnormally high blood glucose and lipid levels in the treatmen... | 08/02/1983 |
| 4393049 | Treatment for obesity Use of γ-linolenic acid and related materials alone or with zinc or ଲ-lactam antibiotics to treat obesity.... | 07/12/1983 |
| 4391826 | Phenethanolamines, compositions containing the same, and method for effecting weight control Optically active N-3-(4-substituted phenyl)propyl-ଲ-phenethanolamines are provided as well as pharmaceutical compositions containing such compounds. A method for effecting weight control in obese animals utilizing optically active phenethanolamines ... | 07/05/1983 |
| 4385066 | Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions Compounds of formula (II): ##STR1## or a pharmaceutically acceptable salt, lower alkyl or aralkyl ester or amide thereof, wherein R1 and R2, which may be the same or different, are each of a hydrogen atom or a methyl group, n is... | 05/24/1983 |
| 4382958 | Secondary amines and compositions for treatment of hypoglycaemia or obesity A compound of formula (I): ##STR1## or a salt thereof; wherein R1 is hydrogen, methyl or ethyl; R2 is hydrogen, methyl or ethyl; R3 is hydrogen, fluorine, chlorine, bromine or trifluoromethyl; each of R4 an... | 05/10/1983 |
| 4341793 | Secondary amines and their use in pharmaceutical compositions Compounds of formula (III): ##STR1## and esters, amides and pharmaceutically acceptable salts thereof, wherein A1 is hydrogen or methyl; A2 is hydrogen or methyl; n is 1, 2 or 3; and R is hydrogen, chlorine, bromine, hydroxy, nitro, ... | 07/27/1982 |
| 4338333 | Ethanamine derivatives their preparation and use in pharmaceutical compositions The compounds of formula (II): ##STR1## in which R1 is a hydrogen, fluorine, chlorine or bromine atom or a hydroxyl, hydroxymethyl, methyl, methoxyl, amino, formamido, acetamido, methylsulphonylamido, nitro, benzyloxy, methylsulphonylmethy... | 07/06/1982 |
| 4329358 | 3-Chlorophenyl anti-obesity agents Compounds of formula (III): ##STR1## and esters, amides and pharmaceutically acceptable salts thereof, wherein A1 is hydrogen or methyl; A2 is hydrogen or methyl; and n is 1, 2 or 3 have anti-obesity activity. Methods for their prepa... | 05/11/1982 |
| 4317915 | Novel thiophene derivatives Thiophene derivatives having utility as blood lipid lowering agents and as antiobesity agents are disclosed.... | 03/02/1982 |
| 4315860 | 5-Pyrrolidino, piperidino or N'-2-hydroxyethylpiperazino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepines Compounds of the formula ##STR1## wherein R1 is hydrogen, alkyl of 1 to 6 carbon atoms or amino, R2 is hydrogen or alkyl of 1 to 6 carbon atoms, with the provisos that (1) at least one of R1 and R2 is not a tert... | 02/16/1982 |
| 4309443 | Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them A compound of the formula (I): ##STR1## or a pharmaceutically acceptable ester, amide or salt thereof wherein R1 is a hydrogen, fluorine, chlorine or bromine atom or a hydroxyl, hydroxymethyl, methyl, methoxyl, amino, formamido, acetamido,... | 01/05/1982 |
| 4299968 | Novel thiophene compounds Novel thiophene compounds having utility as biotin intermediates and blood lipid lowering agents, as well as related processes and intermediates, are disclosed.... | 11/10/1981 |
| 4288433 | Cosmetic compositions having a slimming action The invention provides compositions which have a slimming and anti-cellulitis action when applied to the body, topically with massage or using trans-cutaneous electrophoresis. The compositions contain, in combination, a thioether and a xanthine derivative... | 09/08/1981 |
| 4285946 | 4-Amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides What is disclosed are 4-amino-2-ureido (or -thioureido)-pyrimidine-5-carboxylic acid anilides of the formula ##STR1## further defined in the specification, and physiologically acceptable acid addition salts thereof, methods for treating adiposity and... | 08/25/1981 |
| 4272533 | N-Phenylindoline derivatives, and pharmaceutical compositions containing them 2-aminoethyl-1-phenylindolines are useful as anti-diabetic and anti-obesity agents.... | 06/09/1981 |
| 4246259 | Higher alkyl diaryl sulfonium salts Higher alkyl diaryl sulfonium salts, e.g., octadecyldiphenylsulfonium tetrafluoroborate, are useful as anti-obesity agents.... | 01/20/1981 |
